TenAces Biosciences

TenAces Biosciences Overview

TenAces Biosciences is a biopharmaceutical company focused on the development of molecular glue therapeutics. The molecular glues are small molecules that can induce or stabilize the interaction between an E3 ligase and a target protein. This enhanced binding accelerates the tagging with ubiquitin, and subsequent removal of the target protein by the proteasome. The company's approach, based on machine learning, 3D modeling and virtual compound screening, allows for the development of rationally designed molecular glues for a wide range of diseases.

Cumulative Funding Raised Over Time ($)

Latest News

Jan 30, 2024 · www.prnewswire.com

growth-positive

AION Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery

AION Labs, a venture studio comprising several pharmaceutical and tech companies, has announced the formation of TenAces Biosciences. The startup is developing a novel approach to discover new molecular glue therapies using machine learning. The platform is expected to facilitate the discovery and development of molecular glue therapies for enhanced targeted protein degradation. TenAces emerged from AION Labs fifth startup challenge to develop an AI platform to identify naturally occurring protein interactions leading to targeted protein degradation.

PartnersInvestment

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

Rehovot, Israel

Photos & Videos

No files yet

TenAces Biosciences Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info